-
Akula SM, Pramod NP, Wang FZ, Chandran B, 2002: Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells[J]. Cell, 108, 407-419. doi: 10.1016/S0092-8674(02)00628-1
-
Aluigi MG, Albini A, Carlone S, Repetto L, De Marchi R, Icardi A, Moro M, Noonan D, Benelli R, 1996: KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi’s sarcoma[J]. Res Virol, 147, 267-275. doi: 10.1016/0923-2516(96)82285-0
-
Angius F, Uda S, Piras E, Spolitu S, Ingianni A, Batetta B, Pompei R, 2015: Neutral lipid alterations in human herpesvirus 8-infected HUVEC cells and their possible involvement in neo-angiogenesis[J]. BMC Microbiol, 15, 74-. doi: 10.1186/s12866-015-0415-7
-
Avey D, Brewers B, Zhu F, 2015: Recent advances in the study of Kaposi’s sarcoma-associated herpesvirus replication and pathogenesis[J]. Virol Sin, 30, 130-145. doi: 10.1007/s12250-015-3595-2
-
Ballestas ME, Chatis PA, Kaye KM, 1999: Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen[J]. Science, 284, 641-644. doi: 10.1126/science.284.5414.641
-
Bhatt AP, Jacobs SR, Freemerman AJ, Makowski L, Rathmell JC, Dittmer DP, Damania B, 2012: Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma[J]. Proc Natl Acad Sci U S A, 109, 11818-11823. doi: 10.1073/pnas.1205995109
-
Birkmann A, Mahr K, Ensser A, Yaguboglu S, Titgemeyer F, Fleckenstein B, Neipel F, 2001: Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8[J]. 1. J Virol, 75, 11583-11593. doi: 10.1128/JVI.75.23.11583-11593.2001
-
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chene G, Morlat P, 2004: Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy[J]. Cancer, 101, 317-324. doi: 10.1002/cncr.v101:2
-
Cao Y, Qiao J, Lin Z, Zabaleta J, Dai L, Qin Z, 2017: Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma[J]. Oncotarget, 8, 15220-15229.
-
Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM, 1995: Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas[J]. N Engl J Med, 332, 1186-1191. doi: 10.1056/NEJM199505043321802
-
Chakraborty S, ValiyaVeettil M, Sadagopan S, Paudel N, Chandran B, 2011: c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi’s sarcoma-associated herpesvirus infection in endothelial cells[J]. J Virol, 85, 12410-12430. doi: 10.1128/JVI.05953-11
-
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS, 1994: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma[J]. Science, 266, 1865-1869. doi: 10.1126/science.7997879
-
Chen YB, Rahemtullah A, Hochberg E, 2007: Primary effusion lymphoma[J]. Oncologist, 12, 569-576. doi: 10.1634/theoncologist.12-5-569
-
Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S, 1996: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate[J]. Nature, 381, 800-803. doi: 10.1038/381800a0
-
Dai L, Plaisance-Bonstaff K, Voelkel-Johnson C, Smith CD, Ogretmen B, Qin Z, Parsons C, 2014: Sphingosine kinase-2 maintains viral latency and survival for KSHV-infected endothelial cells[J]. PLoS One, 9, e102314-. doi: 10.1371/journal.pone.0102314
-
Dai L, Qin Z, Defee M, Toole BP, Kirkwood KL, Parsons C, 2012: Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts[J]. Cancer Lett, 318, 214-220. doi: 10.1016/j.canlet.2011.12.019
-
Dai L, Trillo-Tinoco J, Bai A, Chen Y, Bielawski J, Del Valle L, Smith CD, Ochoa AC, Qin Z, Parsons C, 2015: Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression[J]. Oncotarget, 6, 24246-24260. doi: 10.18632/oncotarget.v6i27
-
Delgado T, Sanchez EL, Camarda R, Lagunoff M, 2012: Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection[J]. PLoS Pathog, 8, e1002866-. doi: 10.1371/journal.ppat.1002866
-
Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C, 1999: Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma[J]. Proc Natl Acad Sci U S A, 96, 4546-4551. doi: 10.1073/pnas.96.8.4546
-
Flaitz CM, Jin YT, Hicks MJ, Nichols CM, Wang YW, Su IJ, 1997: Kaposi’s sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi’s sarcoma: a PCR and clinicopathologic study[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83, 259-264. doi: 10.1016/S1079-2104(97)90014-7
-
Fontana JM, Mygatt JG, Conant KL, Parsons CH, Kaleeba JA, 2014: Kaposi’s Sarcoma-Associated Herpesvirus Subversion of the Anti-Inflammatory Response in Human Skin Cells Reveals Correlates of Latency and Disease Pathogenesis[J]. J Skin Cancer, 2014, 246076-.
-
Garrigues HJ, Rubinchikova YE, Dipersio CM, Rose TM, 2008: Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi’s sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor[J]. J Virol, 82, 1570-1580. doi: 10.1128/JVI.01673-07
-
Gonzalez-Pardo V, D’Elia N, Verstuyf A, Boland R, Russo de Boland A, 2012: NFkappaB pathway is down-regulated by 1alpha, 25(OH)(2)-vitamin D(3) in endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein coupled receptor[J]. Steroids, 77, 1025-1032. doi: 10.1016/j.steroids.2012.05.006
-
Gonzalez-Pardo V, Martin D, Gutkind JS, Verstuyf A, Bouillon R, de Boland AR, Boland RL, 2010: 1 Alpha, 25-dihydroxyvitamin D3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein-coupled receptor in vitro and in vivo[J]. Endocrinology, 151, 23-31. doi: 10.1210/en.2009-0650
-
Gonzalez-Pardo V, Verstuyf A, Boland R, Russo de Boland A, 2013: Vitamin D analogue TX 527 down-regulates the NF-kappaB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirus[J]. Br J Pharmacol, 169, 1635-1645. doi: 10.1111/bph.12219
-
Gorres KL, Daigle D, Mohanram S, Miller G, 2014: Activation and repression of Epstein-Barr Virus and Kaposi’s sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids[J]. J Virol, 88, 8028-8044. doi: 10.1128/JVI.00722-14
-
Grisotto MG, Garin A, Martin AP, Jensen KK, Chan P, Sealfon SC, Lira SA, 2006: The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells[J]. J Clin Invest, 116, 1264-1273. doi: 10.1172/JCI26666
-
Grundhoff A, Ganem D, 2004: Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis[J]. J Clin Invest, 113, 124-136. doi: 10.1172/JCI200417803
-
Hahn AS, Kaufmann JK, Wies E, Naschberger E, Panteleev-Ivlev J, Schmidt K, Holzer A, Schmidt M, Chen J, Konig S, Ensser A, Myoung J, Brockmeyer NH, Sturzl M, Fleckenstein B, Neipel F, 2012: The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi’s sarcoma-associated herpesvirus[J]. Nat Med, 18, 961-966. doi: 10.1038/nm.2805
-
Janes PW, Ley SC, Magee AI, Kabouridis PS, 2000: The role of lipid rafts in T cell antigen receptor (TCR) signalling[J]. Semin Immunol, 12, 23-34. doi: 10.1006/smim.2000.0204
-
Kaleeba JA, Berger EA, 2006: Kaposi’s sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT[J]. Science, 311, 1921-1924. doi: 10.1126/science.1120878
-
Kang S, Myoung J, 2017: Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas[J]. J Microbiol, 55, 319-329. doi: 10.1007/s12275-017-7075-2
-
Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA, 2000: Synthesis and antitumor activity of an inhibitor of fatty acid synthase[J]. Proc Natl Acad Sci U S A, 97, 3450-3454. doi: 10.1073/pnas.97.7.3450
-
Lager I, Altini M, Coleman H, Ali H, 2003: Oral Kaposi’s sarcoma: a clinicopathologic study from South Africa[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 96, 701-710. doi: 10.1016/S1079-2104(03)00370-6
-
Lebbe C, de Cremoux P, Millot G, Podgorniak MP, Verola O, Berger R, Morel P, Calvo F, 1997: Characterization of in vitro culture of HIV-negative Kaposi’s sarcoma-derived cells[J]. In vitro responses to alfa interferon. Arch Dermatol Res, 289, 421-428.
-
Maceyka M, Payne SG, Milstien S, Spiegel S, 2002: Sphingosine kinase, sphingosine-1-phosphate, and apoptosis[J]. Biochim Biophys Acta, 1585, 193-201. doi: 10.1016/S1388-1981(02)00341-4
-
Mesri EA, Cesarman E, Boshoff C, 2010: Kaposi’s sarcoma and its associated herpesvirus[J]. Nat Rev Cancer, 10, 707-719. doi: 10.1038/nrc2888
-
Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, Gutkind JS, 2003: Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi’s sarcomagenesis and can promote the tumorigenic potential of viral latent genes[J]. Cancer Cell, 3, 23-36. doi: 10.1016/S1535-6108(02)00237-4
-
Naranatt PP, Akula SM, Zien CA, Krishnan HH, Chandran B, 2003: Kaposi’s sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity[J]. J Virol, 77, 1524-1539. doi: 10.1128/JVI.77.2.1524-1539.2003
-
Ogretmen B, Hannun YA, 2004: Biologically active sphingolipids in cancer pathogenesis and treatment[J]. Nat Rev Cancer, 4, 604-616. doi: 10.1038/nrc1411
-
Porter JA, Young KE, Beachy PA, 1996: Cholesterol modification of hedgehog signaling proteins in animal development[J]. Science, 274, 255-259. doi: 10.1126/science.274.5285.255
-
Qin Z, Dai L, Trillo-Tinoco J, Senkal C, Wang W, Reske T, Bonstaff K, Del Valle L, Rodriguez P, Flemington E, Voelkel-Johnson C, Smith CD, Ogretmen B, Parsons C, 2014: Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma[J]. Mol Cancer Ther, 13, 154-164.
-
Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Caballero A, Sivakumar R, Varga L, Bottero V, Chandran B, 2007: Lipid rafts of primary endothelial cells are essential for Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry[J]. J Virol, 81, 7941-7959. doi: 10.1128/JVI.02848-06
-
Rappocciolo G, Jenkins FJ, Hensler HR, Piazza P, Jais M, Borowski L, Watkins SC, Rinaldo CR, 2006: DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages[J]. J Immunol, 176, 1741-1749. doi: 10.4049/jimmunol.176.3.1741
-
Reichart PA, 2003: Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi’s sarcoma[J]. Med Microbiol Immunol, 192, 165-169. doi: 10.1007/s00430-002-0175-5
-
Roy S, Luetterforst R, Harding A, Apolloni A, Etheridge M, Stang E, Rolls B, Hancock JF, Parton RG, 1999: Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains[J]. Nat Cell Biol, 1, 98-105. doi: 10.1038/10067
-
Saddoughi SA, Ogretmen B, 2013: Diverse functions of ceramide in cancer cell death and proliferation[J]. Adv Cancer Res, 117, 37-58. doi: 10.1016/B978-0-12-394274-6.00002-9
-
Schulz TF, 2006: The pleiotropic effects of Kaposi’s sarcoma herpesvirus[J]. J Pathol, 208, 187-198. doi: 10.1002/(ISSN)1096-9896
-
Sharma-Walia N, Chandran K, Patel K, Veettil MV, Marginean A, 2014: The Kaposi’s sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis[J]. J Virol, 88, 2131-2156. doi: 10.1128/JVI.02786-13
-
Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, Chandran B, 2005: ERK1/2 and MEK1/2 induced by Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection[J]. J Virol, 79, 10308-10329. doi: 10.1128/JVI.79.16.10308-10329.2005
-
Sharma-Walia N, Naranatt PP, Krishnan HH, Zeng L, Chandran B, 2004: Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements[J]. J Virol, 78, 4207-4223. doi: 10.1128/JVI.78.8.4207-4223.2004
-
Sheets ED, Holowka D, Baird B, 1999: Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes[J]. J Cell Biol, 145, 877-887. doi: 10.1083/jcb.145.4.877
-
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d’Agay MF, Clauvel JP, Raphael M, Degos L, 1995: Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease[J]. Blood, 86, 1276-1280.
-
Strub GM, Maceyka M, Hait NC, Milstien S, Spiegel S, 2010: Extracellular and intracellular actions of sphingosine-1-phosphate[J]. Adv Exp Med Biol, 688, 141-155. doi: 10.1007/978-1-4419-6741-1
-
Suares A, Russo de Boland A, Verstuyf A, Boland R, Gonzalez-Pardo V, 2015: The proapoptotic protein Bim is up regulated by 1alpha, 25-dihydroxyvitamin D3 and its receptor agonist in endothelial cells and transformed by viral GPCR associated to Kaposi sarcoma[J]. Steroids, 102, 85-91. doi: 10.1016/j.steroids.2015.08.005
-
Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G, 1998: A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus[J]. Proc Natl Acad Sci U S A, 95, 10866-10871. doi: 10.1073/pnas.95.18.10866
-
Sychev ZE, Hu A, DiMaio TA, Gitter A, Camp ND, Noble WS, Wolf-Yadlin A, Lagunoff M, 2017: Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism[J]. PLoS Pathog, 13, e1006256-. doi: 10.1371/journal.ppat.1006256
-
Tansey MG, Baloh RH, Milbrandt J, Johnson EM, 2000: GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival[J]. Neuron, 25, 611-623. doi: 10.1016/S0896-6273(00)81064-8
-
Wang C, Xu C, Sun M, Luo D, Liao DF, Cao D, 2009: Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis[J]. Biochem Biophys Res Commun, 385, 302-306. doi: 10.1016/j.bbrc.2009.05.045
-
Wang HW, Pittaluga S, Jaffe ES, 2016: Multicentric Castleman disease: Where are we now?[J]. Semin Diagn Pathol, 33, 294-306. doi: 10.1053/j.semdp.2016.05.006
-
Wei F, Zhu Q, Ding L, Liang Q, Cai Q, 2016: Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis[J]. Virol Sin, 31, 395-405. doi: 10.1007/s12250-016-3817-2
-
Yu X, Shahir AM, Sha J, Feng Z, Eapen B, Nithianantham S, Das B, Karn J, Weinberg A, Bissada NF, Ye F, 2014: Short-Chain Fatty Acids from Periodontal Pathogens Suppress Histone Deacetylases, EZH2, and SUV39H1 To Promote Kaposi’s Sarcoma-Associated Herpesvirus Replication[J]. J Virol, 88, 4466-4479. doi: 10.1128/JVI.03326-13